Thanks EB.
Something to ponder:
“The presented vaccination approach may substitute for treatment with trastuzumab..”
Well what would substituting Imugene’s therapy for Tradtuzumab mean in a dollar loss sense for
“Submitted price Trastuzumab deruxtecan, 100 mg, vial: $2,440.00 Treatment costs The cost of trastuzumab deruxtecan per 21-day cycle is $9,574 or $165,949 annually if patients remain on treatment for a full year
My opinion only DYOR
Fact Finder
Media Thread, page-14781
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.001(1.79%) |
Mkt cap ! $418.9M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $461.9K | 8.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1082545 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 603058 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |